Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

PLGA - encapsulated harmine derivative H-2-168: A promising therapeutic agent for mitigating liver damage in hepatic hydatid disease

Saved in:
Bibliographic Details
Published in:PLoS Neglected Tropical Disease
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1871837991777861632
collection WordPress RSS
FRELIP Feed Integration
container_title PLoS Neglected Tropical Disease
description
discipline_display Communicable Diseases, Epidemiology
discipline_facet Communicable Diseases, Epidemiology
format Online Article
RSS Article
genre Journal Article
id rss_article:106996
institution FRELIP
journal_source_facet PLoS Neglected Tropical Disease
last_indexed 2026-07-27T03:43:37.199Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle PLGA - encapsulated harmine derivative H-2-168: A promising therapeutic agent for mitigating liver damage in hepatic hydatid disease
Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
sub_discipline_display General
sub_discipline_facet General
subject_display Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
subject_facet Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
title PLGA - encapsulated harmine derivative H-2-168: A promising therapeutic agent for mitigating liver damage in hepatic hydatid disease
title_alt Derivado de harmina H-2-168 encapsulado en PLGA: Un agente terapéutico prometedor para mitigar el daño hepático en la hidatidosis hepática
Dérivé d'harmine H-2-168 encapsulé dans du PLGA : un agent thérapeutique prometteur pour atténuer les lésions hépatiques dans l'hydatidose hépatique
Derivado de harmina H-2-168 encapsulado em PLGA: Um agente terapêutico promissor para mitigar danos hepáticos na doença hidática hepática
title_auth PLGA - encapsulated harmine derivative H-2-168: A promising therapeutic agent for mitigating liver damage in hepatic hydatid disease
title_es_txt Derivado de harmina H-2-168 encapsulado en PLGA: Un agente terapéutico prometedor para mitigar el daño hepático en la hidatidosis hepática
title_fr_txt Dérivé d'harmine H-2-168 encapsulé dans du PLGA : un agent thérapeutique prometteur pour atténuer les lésions hépatiques dans l'hydatidose hépatique
title_full PLGA - encapsulated harmine derivative H-2-168: A promising therapeutic agent for mitigating liver damage in hepatic hydatid disease
title_fullStr PLGA - encapsulated harmine derivative H-2-168: A promising therapeutic agent for mitigating liver damage in hepatic hydatid disease
title_full_unstemmed PLGA - encapsulated harmine derivative H-2-168: A promising therapeutic agent for mitigating liver damage in hepatic hydatid disease
title_pt_txt Derivado de harmina H-2-168 encapsulado em PLGA: Um agente terapêutico promissor para mitigar danos hepáticos na doença hidática hepática
title_short PLGA - encapsulated harmine derivative H-2-168: A promising therapeutic agent for mitigating liver damage in hepatic hydatid disease
title_sort plga - encapsulated harmine derivative h-2-168: a promising therapeutic agent for mitigating liver damage in hepatic hydatid disease
topic Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
url https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014483